LABOGENE A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  2.2% 2.2% 2.2% 2.2% 1.5%  
Bankruptcy risk  1.0% 0.7% 0.5% 0.5% 0.4%  
Credit score (0-100)  87 93 99 98 99  
Credit rating  A AA AAA AA AAA  
Credit limit (kDKK)  656.5 1,705.4 1,820.4 1,703.3 2,124.7  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  19,682 19,074 17,269 13,643 16,898  
EBITDA  5,694 12,623 4,222 2,005 3,193  
EBIT  5,499 12,437 4,056 1,976 3,183  
Pre-tax profit (PTP)  5,473.5 5,991.4 3,771.3 1,667.6 2,908.0  
Net earnings  4,242.2 4,659.7 2,922.4 1,294.2 2,261.7  
Pre-tax profit without non-rec. items  5,474 12,303 3,771 1,668 2,908  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  269 150 40.9 12.7 2.3  
Shareholders equity total  4,742 9,402 12,324 13,618 15,880  
Interest-bearing liabilities  6,166 3,699 3,572 537 3,144  
Balance sheet total (assets)  16,755 21,934 27,546 21,580 28,949  

Net Debt  3,444 2,479 1,916 207 1,905  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  19,682 19,074 17,269 13,643 16,898  
Gross profit growth  0.0% -3.1% -9.5% -21.0% 23.9%  
Employees  26 23 25 23 24  
Employee growth %  0.0% -11.5% 8.7% -8.0% 4.3%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  16,755 21,934 27,546 21,580 28,949  
Balance sheet change%  0.0% 30.9% 25.6% -21.7% 34.2%  
Added value  5,693.9 12,622.6 4,221.9 2,141.9 3,193.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  135 1,834 674 294 152  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  27.9% 65.2% 23.5% 14.5% 18.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  32.6% 64.3% 16.4% 8.0% 12.6%  
ROI %  52.6% 102.6% 26.4% 12.3% 18.1%  
ROE %  89.5% 65.9% 26.9% 10.0% 15.3%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  28.3% 42.9% 44.7% 64.7% 55.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  60.5% 19.6% 45.4% 10.3% 59.7%  
Gearing %  130.0% 39.3% 29.0% 3.9% 19.8%  
Net interest  0 0 0 0 0  
Financing costs %  -0.5% 2.7% 7.8% 15.0% 15.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.9 1.1 1.2 1.2 1.1  
Current Ratio  1.5 1.9 1.9 3.3 2.3  
Cash and cash equivalent  2,722.2 1,219.8 1,656.6 330.0 1,239.4  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  5,057.6 8,801.0 11,262.1 11,996.2 13,903.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  219 549 169 93 133  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  219 549 169 87 133  
EBIT / employee  211 541 162 86 133  
Net earnings / employee  163 203 117 56 94